中华胰腺病杂志
中華胰腺病雜誌
중화이선병잡지
CHINESE JOURNAL OF PANCREATOLOGY
2012年
1期
16-18
,共3页
李雷%刘军%宛新建%陆伦根%郑萍%董育玮%黄春兰%王兴鹏%袁耀宗
李雷%劉軍%宛新建%陸倫根%鄭萍%董育瑋%黃春蘭%王興鵬%袁耀宗
리뢰%류군%완신건%륙륜근%정평%동육위%황춘란%왕흥붕%원요종
胰腺肿瘤%细胞运动%内皮细胞%血管生成抑制剂
胰腺腫瘤%細胞運動%內皮細胞%血管生成抑製劑
이선종류%세포운동%내피세포%혈관생성억제제
Pancreatic neoplasms%Cell movement%Endothelial cells%Anpogenesis inhibitors
目的 观察Vasostatin基因表达对胰腺癌内皮细胞迁移能力的影响.方法 应用不同浓度的载有Vasostatin基因的腺病毒(Ad-vasosiatin)感染胰腺癌内皮细胞,以Ad-lacZ感染及磷酸盐缓冲液(PBS)作为对照组.应用损伤修复、Transwell小室、小管形成3种不同方法观察胰腺癌内皮细胞迁移能力的变化及其与感染病毒的量效关系.结果 培养48 h后,PBS组与Ad-lacZ组的划痕损伤区域几乎完全恢复;而Ad-vasostatin组的划痕损伤区域无明显恢复.以MOI 1、2、5感染细胞,Ad-lacZ组的迁移率分别为(84.7±2.6)%、(80.7±1.7)%和(81.3±4.0)%;Ad-vasostatin组为(77.7±2.1)%、(67.3±2.1)%和(38.8±2.1)%,Ad-vasostatin呈剂量依赖性抑制细胞迁移率,MOI=5时的细胞迁移率大幅度降低(F=180.88,P<0.05).以MOI1、5、10感染时,Ad-lacZ组的小管形成数分别为(118±6)、(120±6)、(82±5)个;Ad-vasostatin组为(65±4)、(21±4)、(4±1)个,Ad-vasostatin呈剂量依赖性抑制胰腺癌内皮细胞的小管形成,在MOI=10时已很难形成管状结构(F =300.85,P<0.05).结论 Vasostatin基因能显著抑制胰腺癌内皮细胞的体外迁移能力,且呈剂量依赖性.
目的 觀察Vasostatin基因錶達對胰腺癌內皮細胞遷移能力的影響.方法 應用不同濃度的載有Vasostatin基因的腺病毒(Ad-vasosiatin)感染胰腺癌內皮細胞,以Ad-lacZ感染及燐痠鹽緩遲液(PBS)作為對照組.應用損傷脩複、Transwell小室、小管形成3種不同方法觀察胰腺癌內皮細胞遷移能力的變化及其與感染病毒的量效關繫.結果 培養48 h後,PBS組與Ad-lacZ組的劃痕損傷區域幾乎完全恢複;而Ad-vasostatin組的劃痕損傷區域無明顯恢複.以MOI 1、2、5感染細胞,Ad-lacZ組的遷移率分彆為(84.7±2.6)%、(80.7±1.7)%和(81.3±4.0)%;Ad-vasostatin組為(77.7±2.1)%、(67.3±2.1)%和(38.8±2.1)%,Ad-vasostatin呈劑量依賴性抑製細胞遷移率,MOI=5時的細胞遷移率大幅度降低(F=180.88,P<0.05).以MOI1、5、10感染時,Ad-lacZ組的小管形成數分彆為(118±6)、(120±6)、(82±5)箇;Ad-vasostatin組為(65±4)、(21±4)、(4±1)箇,Ad-vasostatin呈劑量依賴性抑製胰腺癌內皮細胞的小管形成,在MOI=10時已很難形成管狀結構(F =300.85,P<0.05).結論 Vasostatin基因能顯著抑製胰腺癌內皮細胞的體外遷移能力,且呈劑量依賴性.
목적 관찰Vasostatin기인표체대이선암내피세포천이능력적영향.방법 응용불동농도적재유Vasostatin기인적선병독(Ad-vasosiatin)감염이선암내피세포,이Ad-lacZ감염급린산염완충액(PBS)작위대조조.응용손상수복、Transwell소실、소관형성3충불동방법관찰이선암내피세포천이능력적변화급기여감염병독적량효관계.결과 배양48 h후,PBS조여Ad-lacZ조적화흔손상구역궤호완전회복;이Ad-vasostatin조적화흔손상구역무명현회복.이MOI 1、2、5감염세포,Ad-lacZ조적천이솔분별위(84.7±2.6)%、(80.7±1.7)%화(81.3±4.0)%;Ad-vasostatin조위(77.7±2.1)%、(67.3±2.1)%화(38.8±2.1)%,Ad-vasostatin정제량의뢰성억제세포천이솔,MOI=5시적세포천이솔대폭도강저(F=180.88,P<0.05).이MOI1、5、10감염시,Ad-lacZ조적소관형성수분별위(118±6)、(120±6)、(82±5)개;Ad-vasostatin조위(65±4)、(21±4)、(4±1)개,Ad-vasostatin정제량의뢰성억제이선암내피세포적소관형성,재MOI=10시이흔난형성관상결구(F =300.85,P<0.05).결론 Vasostatin기인능현저억제이선암내피세포적체외천이능력,차정제량의뢰성.
Objective To investigate the effect of vasostatin on the migration of pancreatic cancer endothelial cells.Methods Ad-vasostatin with different concentrations of vasostatin was used to transfect pancreatic cancer endothelial cells.Ad-LacZ transfection and PBS was used as control.The effect of vasostatin gene mediated by adenovirus on the migration of pancreatic cancer endothelial cells was measured by woundhealing assay,transwell migration assay,and tube formation assay.Results The scratched lines in PBS group and Ad-LacZ group were almost healed 48 hours later,while the lines in Ad-vasostatin group were rarely healed.At the MOI of 1,2,5,the migration rate of Ad-Laz group was ( 84.7 ± 2.6) %,(80.7 ± 1.7 ) % and (81.3±4.0)%,while the corresponding values were (77.7 ±2.1)%,(67.3 ±2.1)% and (38.8 ±2.1 ) % in Ad-vasostatin group.Transwell migration assay indicated that the number of migrated cells in Advasostatin group was inhibited in a dose-dependant manner,at the MOI of 5,the migration became significantly decreased (F=180.88,P <0.05).At the MOI of 1,5,10,the number of tubes in Ad-LacZ group was 118±6,120±6 and 82±5,while the corresponding values were 65±4,21±4 and 4 ±1 in Ad-vasostatin group.The number of tubes of pancreatic cancer endothelial cells was inhibited by Ad-vasostatin in a dose-dependant manner,at the MOI of 10, it was difficult to form the tubes (F-300.85,P<0.05). Conclusions The vasostatin gene mediated by adenovirus has a significant inhibitory effect on the migation of pancreatic cancer endothelial cells in vitro in a dose-dependent manner.